companydata.dkcompanydata.dk

ExSeed Health ApS: Financial statements 2024

CVR: 38677942

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

ExSeed Health ApS (CVR 38677942) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 5,450,653 and a net result of DKK 1,358,418 compared with DKK 1,108,837 the year before. That is an increase of 8.4% compared with the year before. Equity in the 2024 report amounted to DKK 8,324,248. The solvency ratio was 78%. The company had 7 employees in the financial year.

Gross Profit
DKK 5,450,653
Profit/Loss
DKK 1,358,418
Equity
DKK 8,324,248
Total Assets
DKK 10,669,261
Employees
7

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024-5.5M1.4M8.3M7
2023-5M1.1M-7.6M6
2022-1.9M-622K-8.7M6
2021-144K-2.7M-8.1M6
2020-196K-2.3M-5.4M3

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

ExSeed Health ApS: The 2023 annual report is outApr 4, 2024

ExSeed Health ApS has published its annual report for 2023. Gross profit came to DKK 5,029,011, and the net result was DKK 1,108,837.

About ExSeed Health ApS

ExSeed Health ApS is a Danish company of the type Anpartsselskab based in København S, founded in 2017. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The management consists of Morten Gorm Ulsted. The board consists of Emil Andersen (chair) and Daniel Gewecke Daugaard-Jensen. The company is owned by Exseed Health Limited. The company has 12 employees (2026). In 2025, the company reported a gross profit of DKK 3,262,339 and a net result of DKK -397,883 compared with DKK 1,358,418 the year before. Equity in the 2025 report amounted to DKK 7,926,365.

Source: annual report 2025, Danish Business Authority

Other financial years